secwatch / observer

8-K filed April 8, 2025, 7:59 PM ET ticker JAZZ CIK 0001232524

litigation confidence high sentiment negative materiality 0.80

Jazz Pharma to pay $145M to settle Xyrem antitrust class action; records Q1 charge

Jazz Pharmaceuticals plc

Jazz Pharmaceuticals Ireland subsidiary agrees to pay $145M lump sum to settle indirect Xyrem purchaser class action.
Company will record a pre-tax charge of approximately $145M in Q1 2025, funded by cash on hand.
Settlement remains subject to court approval; Jazz denies all alleged wrongdoing.
The settlement resolves the majority of claims in the multi-district litigation; additional settlements with remaining plaintiffs may be significant.

Machine-readable event card

schema_version: secwatch.filing_event.v1
accession: 0001193125-25-075871
form_type: 8-K
ticker: JAZZ
cik: 0001232524
company_name: Jazz Pharmaceuticals plc
filed_at: 2025-04-08T23:59:59+00:00
discovered_at: 2026-05-14T18:02:47.752636+00:00
generated_at: 2026-05-23T18:53:23.029119+00:00
sec_items: ["1.01"]
event_type: litigation
sentiment: negative
materiality_score: 0.8
calibrated_materiality_score: 0.8
confidence: high
secwatch_canonical_url: https://secwatch.observer/filing/0001193125-25-075871
json_url: https://secwatch.observer/filing/0001193125-25-075871.json
markdown_url: https://secwatch.observer/filing/0001193125-25-075871.md
text_url: https://secwatch.observer/filing/0001193125-25-075871.txt
edgar_index_url: https://www.sec.gov/Archives/edgar/data/1232524/000119312525075871/0001193125-25-075871-index.htm
edgar_primary_document_url: https://www.sec.gov/Archives/edgar/data/1232524/000119312525075871/d901769d8k.htm
generated_by_model: deepseek-v4-flash:cloud@v2
review_status: machine_generated
human_reviewed: false
corrected: false
correction_note: null
correction_timestamp: null
superseded_by: null

JSON Markdown Plain text

Comparable filings

CRDF

NMS terminates license agreement with Cardiff Oncology; Cardiff disputes termination

Cardiff Oncology, Inc. May 29, 2026, 5:11 PM ET litigation Items 1.01

same SEC item: 1.01 same event type: litigation similar materiality

Filing page SEC filing

NMHI

Nature's Miracle settles noteholder litigation for $575K; must reserve 222M shares

Nature's Miracle Holding Inc. May 27, 2026, 8:14 PM ET litigation Items 1.01, 9.01

same SEC item: 1.01 same event type: litigation similar materiality

Filing page SEC filing

ICCC

ImmuCell settles Norbrook dispute, to receive $2M payment

IMMUCELL CORP /DE/ May 8, 2026, 7:59 PM ET litigation Items 1.01

same SEC item: 1.01 same event type: litigation similar materiality

Filing page SEC filing

OPY

Oppenheimer settles cash-sweep class action for $70M, to impact Q1 earnings

OPPENHEIMER HOLDINGS INC April 27, 2026, 7:59 PM ET litigation Items 1.01, 9.01

same SEC item: 1.01 same event type: litigation similar materiality

Filing page SEC filing

MKTW

MarketWise settles arbitration with former CEO for $12.16M cash, redeems 520,867 units, terminates TRA rights

MARKETWISE, INC. April 24, 2026, 7:59 PM ET litigation Items 1.01, 9.01

same SEC item: 1.01 same event type: litigation similar materiality

Filing page SEC filing

AGAE

Allied Gaming settles litigation with Knighted for ~$5.94M paid over 3 months; CEO Li personally guarantees payment

Allied Gaming & Entertainment Inc. April 21, 2026, 7:59 PM ET litigation Items 1.01, 5.02, 8.01, 9.01

same SEC item: 1.01 same event type: litigation similar materiality

Filing page SEC filing

SLND

Southland subsidiary settles WA convention center lawsuit; sureties to pay additional $26.5M

Southland Holdings, Inc. April 2, 2026, 7:59 PM ET litigation Items 1.01

same SEC item: 1.01 same event type: litigation similar materiality

Filing page SEC filing

ROIV

Roivant subsidiary Genevant settles LNP patent litigation with Moderna; includes license and payments

Roivant Sciences Ltd. March 23, 2026, 7:59 PM ET litigation Items 1.01, 9.01

same SEC item: 1.01 same event type: litigation similar materiality

Filing page SEC filing

Source: SEC EDGAR

accession 0001193125-25-075871

view filing index on sec.gov

view primary document

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.